In fact, the CDK12 seemed to regulate genes involved in the DDR and thus controlled genomic stability and the loss of the CDK12 was described as a resistant mechanism to PARPi in ovarian cancer [22]. This evidence concerns the gene CDK12 and ovarian carcinoma.